Texas Oncology - DFW — Dallas, Texas

Texas Oncology - DFW is a clinical research site located in Dallas, Texas, United States 75246.

Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

Texas Oncology - DFW has participated in 29 clinical trials with 27 currently active.

Therapeutic areas: Triple Negative Breast Neoplasms, HER2-positive Breast Cancer, Breast Cancer.

Sponsors: Seagen Inc., Seagen, a wholly owned subsidiary of Pfizer, Stemline Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology - DFW?

Texas Oncology - DFW has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology - DFW conducted?

Texas Oncology - DFW has 29 clinical trials on record, with 27 currently active. Their work covers Triple Negative Breast Neoplasms, HER2-positive Breast Cancer, Breast Cancer.

Is Texas Oncology - DFW accredited by Crixeo Health?

Yes — Texas Oncology - DFW holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Texas Oncology - DFW?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.